US Patent Issued to invoX Pharma on Aug. 19 for "Compounds, compositions, and methods for the treatment of disease" (Massachusetts Inventor)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,390,668, issued on Aug. 19, was assigned to invoX Pharma Ltd. (Cambridge, Great Britain).

"Compounds, compositions, and methods for the treatment of disease" was invented by Radhakrishnan P. Iyer (Shrewsbury, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are compounds and compositions for the activation or induction of expression of a pattern recognition receptor (e.g., STING, RIG-I, MDA5), and methods of use thereof."

The patent was filed on June 30, 2023, under Application No. 18/217,025.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1...